Saturday, October 3, 2020 | 6:00 PM
The University of Texas Golf Club
2200 University Club Dr, Austin, TX 78732
Cowboy / Austin Chic
Patty Armstrong, Janet Bates, Swell Cihal, Christal Fitzpatrick, Denyse Peterson, Tammy Marshall, Tim & Laura Revell, Venus Strawn, Keri Wootton
Champions to CureDuchenne is an annual tradition that brings together Austin’s finest for a spectacular evening under the stars. The event features gourmet food, cocktails, casino games, and live and silent auctions for a night of fun and purpose!
The event benefits CureDuchenne and allows them to invest in next generation gene therapy research technology to find a cure for this generation of boys and young men living with Duchenne muscular dystrophy. Through the generous support of the Austin Community, Champions to CureDuchenne has funded more than $2.1M in research to date. And we are just getting started.
CureDuchenne is a national nonprofit that raises awareness and funds research to find a cure for Duchenne muscular dystrophy. Duchenne is the most devastating and lethal muscular disease in children.
Join fellow community and business leaders in the fight to cure Duchenne for a fun and memorable evening of great food and drinks, live and silent auctions, and entertainment.
The most common and fatal form of muscular dystrophy, Duchenne is a devastating, progressive muscle-wasting disease most commonly found in young boys. Affecting 15,000 children in the US and 300,000 worldwide, there is currently no known cure for Duchenne.
The global leader in Duchenne research, patient care and innovation, CureDuchenne is committed to finding and funding a cure for Duchenne muscular dystrophy while delivering the education and resources to support patients, families, caregivers and healthcare providers.
Founded by Paul and Debra Miller in 2003, after their son was diagnosed with the disease, CureDuchenne combines fundraising and venture philanthropy, leveraging donor dollars to maximize support for promising research into effective treatments for those suffering from Duchenne.
With transparency as a core value, investment proceeds are redeployed to support research and other mission critical programs to find a cure.
The proceeds of the night will fund gene editing research that could be transformational for Duchenne patients. It would be a one-time treatment using CRISPR/Cas9 technology that would help correct a majority of the genetic mutations in Duchenne.